课题基金 / 基金详情

Contribution of mast cells to nitrogen mustard pulmonary toxicity

Contribution of mast cells to nitrogen mustard pulmonary toxicity
肥大细胞对氮芥肺毒性的贡献
批准号:
10092555
负责人:
Jared Michael Brown
金额:
$12.46万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
未结题
起止时间:
2010-08-10 至 2025-04-30

项目摘要

项目成果

Jared Michael Brown的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Mast cells are an innate immune cell found in high abundance at mucosal surfaces that interface with the external environment where they play a major role as an immune sentinel to detect injury and insult. Sulfur mustard (SM), a bi-functional alkylating agent, has been used as a chemical warfare agent and exposure causes severe pulmonary, ocular and dermal toxicity. SM causes severe pulmonary damage upon inhalation including damage to airways, tissue remodeling, massive immune cell recruitment, edema, etc. Much of the toxicity to SM is attributed to its alkylating function and DNA damage, however, this does not explain the massive inflammatory response observed nor is it known how these inflammatory responses are elicited in the lung. We hypothesize that activation of mast cells by SM is an initiating step in recruitment and propagation of immune responses in the lung. To test this hypothesis, we will expose wild-type or mast cell deficient mice to nitrogen mustard (NM) (a surrogate for SM) to determine pulmonary responses including tissue damage, inflammation and development of fibrosis. In addition, we will utilize mouse bone marrow-derived mast cells to examine mechanisms by which NM leads to mast cell activation. Specifically, we will investigate whether NM causes mast cell degranulation, lipid mediator production and/or cytokine production. Overall, our goal is to establish a role for mast cells in regulating the pulmonary toxicity to NM thereby providing a novel therapeutic target for prevention and/or treatment of the effects of these chemical warfare agents. The preliminary data generated from this supplement will be used as the basis for a U01 application to the CounterAct program focused on therapeutically targeting mast cells in SM toxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology
  • 批准号:
    10029114
  • 项目类别:
  • 资助金额:
    $63.54万
  • 财政年份:
    2020
  • 负责人:
    Jared Michael Brown
  • 依托单位:
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology
  • 批准号:
    10461915
  • 项目类别:
  • 资助金额:
    $62.69万
  • 财政年份:
    2020
  • 负责人:
    Jared Michael Brown
  • 依托单位:
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology
  • 批准号:
    10212382
  • 项目类别:
  • 资助金额:
    $63.22万
  • 财政年份:
    2020
  • 负责人:
    Jared Michael Brown
  • 依托单位:
Silica Nephropathy and Chronic Kidney Disease of Unknown Etiology
  • 批准号:
    10682599
  • 项目类别:
  • 资助金额:
    $62.97万
  • 财政年份:
    2020
  • 负责人:
    Jared Michael Brown
  • 依托单位:
海外基金